Nebenwirkungen und Risiken bei der Anwendung von Lachgas im Rahmen der Allgemeinanästhesie

  • H.-D. Kamp
Part of the Klinische Anästhesiologie und Intensivtherapie book series (KAI, volume 42)

Zusammenfassung

Lachgas (N2O, Stickoxydul) nimmt unter den Anästhetika eine Sonderstellung ein. Es ist das älteste und am weitesten verbreitete Anästhetikum. Dies verdankte es in der Vergangenheit v. a. seiner analgetischen Wirkung und seiner Nichtentflammbarkeit. In jüngerer Zeit wurden in erster Linie seine günstigen physikalischen Eigenschaften mit der daraus resultierenden guten Steuerbarkeit sowie die vermeintlich fehlende Toxizität und fehlende Kreislaufbeeinträchtigung geschätzt. Gerade die letzten 3 Aspekte führten dabei zu der weitverbreiteten Ansicht, Lachgas entspräche ’ bis auf eine Schwäche bezüglich der hypnotischen Wirksamkeit ’ am ehesten den Vorstellungen von einem idealen Anästhetikum.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Amess JAL, Burman JF, Rees GM, Nacekievill DG, Mollin DL (1978) Megaloblastic hemopoiesis in patients receiving nitrous oxide. Lancet II: 339CrossRefGoogle Scholar
  2. 2.
    Balasaraswathi K, Kumar P, Rao TLK, El-Etr AA (1981) Left ventricular end-diastolic pressure (LVEDP) as an index for nitrous oxide use during coronary artery surgery. Anesthesiology 55: 708PubMedCrossRefGoogle Scholar
  3. 3.
    Brandt L, Pokar H (1983) Das Rediffusionssystem. Anaesthesist 32: 459PubMedGoogle Scholar
  4. 4.
    Cohen EN, Brown BW,Wu ML et al. (1980) Occupational disease in dentistry and chronic exposure to trace anesthetic gases. J Amer Dent Assoc 101: 21Google Scholar
  5. 5.
    Eger II EI (1985) Nitrous oxide/N2O. Elsevier, New YorkGoogle Scholar
  6. 6.
    Eger II EI (1985) Should we not continue to use nitrous oxide? In: Nitrous oxide/N2O (ed. EI Eger II). Elsevier, New YorkGoogle Scholar
  7. 7.
    Eger II EI, Saidman LJ (1965) Hazards of nitrous oxide anesthesia in bowel obstruction and pneumothorax. Anesthesiology 26: 61PubMedCrossRefGoogle Scholar
  8. 8.
    Eger II EI, Lampe GH,Wank LZ,Whitendale P, Cahalan MK, Donegan JH, (1990) Clinical pharmacology of nitrous oxide: An argument for its continued use. Anesth Analg 71: 575PubMedGoogle Scholar
  9. 9.
    Einarsdottir O, Canughey WS (1988) Interactions of the anesthetic nitrous oxide with bovine heart cytochrome c oxidase. J Biol Chem 263: 9199PubMedGoogle Scholar
  10. 10.
    Eisele JH, Smith NT (1972) Cardiovascular effects of 40 percent nitrous oxide in man. Anesth Analg 51: 956PubMedGoogle Scholar
  11. 11.
    Eisele JH,Trenchard D, Stubbs J, Guz A (1969) The immediate cardiac depression by anesthetics in conscious dogs. Br J Anaesth 41: 86PubMedCrossRefGoogle Scholar
  12. 12.
    Fink BR (1955) Diffusion anoxia. Anesthesiology 16: 511PubMedCrossRefGoogle Scholar
  13. 13.
    Hansen TD, Warner DS, Todd MM (1988) Nitrous oxide is a more potent cerebral vasodilator than either halothane or isoflurane. Anesthesiology 69: A537CrossRefGoogle Scholar
  14. 14.
    Konstadt SN, Reich DL,Thys DM (1990) Nitrous oxide does not exacerbate pulmonary hypertension or ventricular dysfunction in patients with mitral valvular disease. Can J Anaesth 37: 613PubMedCrossRefGoogle Scholar
  15. 15.
    Kozmary SV, Lampe GH, Benefiel D et al. (1990) No finding of increased myocardial ischemia during or after carotid endarterectomy under anesthesia with nitrous oxide. Anesth Analg 71: 591PubMedGoogle Scholar
  16. 16.
    Kuschmir H, Rust M, Eisler K (1981) Druckmessungen im Mittelohr bei unterschiedlichen Narkoseverfahren. Laryng Rhinol 60: 418CrossRefGoogle Scholar
  17. 17.
    Landon MJ, Toothill VJ (1986) Effect of nitrous oxide on placental methionine synthase activity. Br J Anaesth 58: 524PubMedCrossRefGoogle Scholar
  18. 18.
    Lappas DG, Buckley MJ, Laver MB, Daggett WM, Lowenstein E (1975) Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery. Anesthesiology 43: 61PubMedCrossRefGoogle Scholar
  19. 19.
    Lassen HCA, Henriksen E, Neukirch F, Kristensen HS (1956) Treatment of tetanus: Severe bone-marrow depressions after prolonged nitrous oxide anaesthesia. Lancet I: 527CrossRefGoogle Scholar
  20. 20.
    Layzer RB (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet II: 1227CrossRefGoogle Scholar
  21. 21.
    Meretoja OA,Takkunen O, Heikkilä H,Wegelius U (1985) Haemodynamic response to nitrous oxide during high-dose fentanyl pancuronium anaesthesia. Acta Anasthesiol Scand 29: 137CrossRefGoogle Scholar
  22. 22.
    Mitchell MM, Prakash O, Rulf ENR, Daele MERM van, Cahalan MK, Roelandt JRTC (1989) Nitrous ocide does not induce myocardial ischemia in patients with ischemic heart disease and poor ventricular function. Anesthesiology 71: 526PubMedCrossRefGoogle Scholar
  23. 23.
    Munson ES, Merrick HC (1966) Effect of nitrous oxide on venous air embolism. Anesthesiology 27: 783PubMedCrossRefGoogle Scholar
  24. 24.
    Nathan HJ (1988) Nitrous oxide worsens myocardial ischemia in isoflurane anesthetized dogs. Anesthesiology 68: 407PubMedCrossRefGoogle Scholar
  25. 25.
    Nunn JF, Chanarin I, Tanner AG, Owen ERTC (1986) oxide anaesthesia. Reversal with folinic acid. Br J Aneasth 58: 1469CrossRefGoogle Scholar
  26. 26.
    Philbin DM, Foex P, Lowenstein E, Ryder WA, Jones LA (1983) Nitrous oxide causes myocardial dysfunction. Anesthesiology 59: A80CrossRefGoogle Scholar
  27. 27.
    Price HL (1976) Myocardial depression by nitrous oxide and its reversal by Ca++. Anesthesiology 44: 211PubMedCrossRefGoogle Scholar
  28. 28.
    Rothammer A (1987) Lachgas in der Kombinationsnarkose. Anasthesist 36: 333Google Scholar
  29. 29.
    Russell GB, Snider MT, Richard RB, Loomis JL (1990) Hyperbaric nitrous oxide as a sole anesthetic agent in humans. Anesth Analg 70: 289PubMedCrossRefGoogle Scholar
  30. 30.
    Samra SK, Deutsch G, Arens JF (1988) Effect of nitrous oxide on global and regional cerebral blood flow in humans. Anesthesiology 69: A536CrossRefGoogle Scholar
  31. 31.
    Smith NT, Calverley RK, Prys-Roberts C, Egger II EI, Jones CW (1978) Impact of nitrous oxide on the circulation during enflurane anesthesia in man. Anesthesiology 48: 345PubMedCrossRefGoogle Scholar
  32. 32.
    Smith NT, Egger II EI, Stoelting RK, Whayne TF, Cullen D, Kadis LB (1970) The cardiovascular and sympathomimetic responses to the addition of nitrous oxide. Anesthesiology 32: 410PubMedCrossRefGoogle Scholar
  33. 33.
    Schuh FT (1975) Nebenwirkungen von Lachgas. Anasthesist 24: 392Google Scholar
  34. 34.
    Schulte am Esch J, Thiemig I, Pfeifer G, Entzian W (1979) Die Wirkung einiger Inhalationsanästhetika auf den intrakraniellen Druck unter besonderer Berücksichtigung des Stickoxidul. Anaesthesist 28: 136PubMedGoogle Scholar
  35. 35.
    Schulte-Sasse U, Hess W,Tarnow J (1982) Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 57: 9PubMedCrossRefGoogle Scholar
  36. 36.
    Stoelting RK, Gibbs PS, Creasser CW, Peterson C (1973) Hemodynamic and ventilatory responses to fentanyl, fentanyl-droperidol, and nitrous oxide in patients with acquired valvular heart disease. Anesthesiology 42: 319CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • H.-D. Kamp

There are no affiliations available

Personalised recommendations